PEARCE CATHERINE (Chief Operating Officer) reported 3 transactions at CINCOR PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2023ACC: 0001209191-23-012892
Officer· Chief Operating Officer
Since Jan 2022
-280.02K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
280.02K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−140.15K
Price / share
—
Trade value
—
% of position
90.3%
2/24/2023
155.15K→15K
Common Stock
Direct
Shares
−15K
Price / share
—
Trade value
—
% of position
New position
2/24/2023
15K→0.00
Common Stock
Indirect
Shares
−1.50K
Price / share
—
Trade value
—
% of position
New position
2/24/2023
1.50K→0.00
Total
Net shares
−156.65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2023 | U · U | −140.15K | — | — | 90.3% | 155.15K | 15K |
| Common Stock Direct | 2/24/2023 | D · Disposition | −15K | — | — | New position | 15K | 0.00 |
| Common Stock Indirect | 2/24/2023 | U · U | −1.50K | — | — | New position | 1.50K | 0.00 |
| Total | −156.65K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
110.14K shares
Shares
−110.14K
Strike price
2.55
Held after
0.00
Exercisable
—
2/24/2023
Restricted Stock Units
Direct
Converts to
Common Stock
13.24K shares
Shares
−13.24K
Strike price
Held after
0.00
Exercisable
—
2/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock110.14K shares | 2/24/2023 | D · Disposition | −110.14K | 2.55 | — | 0.00 |
| Restricted Stock Units Direct | Common Stock13.24K shares | 2/24/2023 | D · Disposition | −13.24K | — | 0.00 |